Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenR37Clinical trial: Optional / allowed

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-25-324

Source: Grants.gov · View original posting ↗

Award
Amount not listed
Deadline
Sep 7, 2028
Letter of intent
Mechanism
R37
Duration
7 yr
Expected awards
Funding cycle
Standard NIH dates
Open date
Jan 6, 2025
Total funding
Clinical trial
Optional / allowed
Early careerGovernmentHigher educationNonprofitSmall businessForeign entities

Research areas

Training & career development

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments:

Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.